Quality of Life in Patients Suffering from Active Exudative Age-Related Macular Degeneration: The EQUADE Study | Zendy

Emilie Matamoros | Zendy; Frédérique Maurel | Zendy; Nadia Léon | Zendy; A. Solomiac | Zendy; Isabelle Bardoulat | Zendy; Marc Joubert | Zendy; Martine Hermans | Zendy; Éric Moser | Zendy; Serge Le Picard | Zendy; Eric H. Souied | Zendy; Nicolas Leveziel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Quality of Life in Patients Suffering from Active Exudative Age-Related Macular Degeneration: The EQUADE Study

Author(s) -

Emilie Matamoros,

Frédérique Maurel,

Nadia Léon,

A. Solomiac,

Isabelle Bardoulat,

Marc Joubert,

Martine Hermans,

Éric Moser,

Serge Le Picard,

Eric H. Souied,

Nicolas Leveziel

Publication year - 2015

Publication title -

ophthalmologica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.639

H-Index - 60

eISSN - 1423-0267

pISSN - 0030-3755

DOI - 10.1159/000433448

Subject(s) - medicine , macular degeneration , ranibizumab , quality of life (healthcare) , visual acuity , observational study , population , ophthalmology , bevacizumab , chemotherapy , nursing , environmental health

Age-related macular degeneration (AMD) is the main cause of visual loss in the elderly population. With the use of anti-vascular endothelial growth factor, the visual outcomes of exudative AMD patients have been improved. This study was aimed at assessing the quality of life (QoL) of exudative AMD patients treated with ranibizumab and at determining its drivers in a real-life setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research